Aadi Bioscience Inc (NAS:AADI)
$ 1.99 0.03 (1.53%) Market Cap: 48.98 Mil Enterprise Value: -29.27 Mil PE Ratio: 0 PB Ratio: 0.62 GF Score: 42/100

Q4 2023 Aadi Bioscience Inc Earnings Call Transcript

Mar 13, 2024 / 12:30PM GMT
Release Date Price: $2.16 (+11.34%)
Operator

Good day and thank you for standing by, and welcome to Aadi Bioscience fourth quarter 2023 earnings conference call. (Operator Instructions) Please note that today's conference is being recorded.

I will now turn the call over to [Audrey Gruls], Head of Corporate Communications for Aadi Bioscience. Ms. Gruls. Please go ahead

Unidentified Company Representative

Thank you. Good morning and welcome to the Adi bioscience conference call to provide an operational update and review results of the fourth quarter and full year 2023. On the call is Dr. Dave Lennon , our President and CEO; Scott Giacobello, our CFO and Chief Medical Officer, Dr. Loretta Itri.

Today, we will provide an overview of operational activity and select financial results for the fourth quarter and full year of 2023. We will open the line for questions at the end of the call.

Following closing comment, a quick reminder that statements made on the call today will include forward looking statements, actual events or results could differ materially from those expressed or implied by

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot